{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:55:40Z","timestamp":1740135340626,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12882-018-1136-6","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T08:32:29Z","timestamp":1543912349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes"],"prefix":"10.1186","volume":"19","author":[{"name":"on behalf of the AMD ANNALS Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3932-3803","authenticated-orcid":false,"given":"Antonio","family":"Mirijello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Viazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Fioretto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Giorda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Ceriello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuspina T.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Guida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Pontremoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"De Cosmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,4]]},"reference":[{"issue":"1","key":"1136_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/jdi.12533","volume":"8","author":"NJ Radcliffe","year":"2017","unstructured":"Radcliffe NJ, Seah JM, Clarke M, MacIsaac RJ, Jerums G, Ekinci EI. Clinical predictive factors in diabetic kidney disease progression. J Diabetes Investig. 2017;8(1):6\u201318.","journal-title":"J Diabetes Investig"},{"issue":"8","key":"1136_CR2","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1001\/archinte.160.8.1093","volume":"160","author":"CT Valmadrid","year":"2000","unstructured":"Valmadrid CT, Klein R, Moss SE, Klein BE. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med. 2000;160(8):1093\u2013100.","journal-title":"Arch Intern Med"},{"issue":"6","key":"1136_CR3","doi-asserted-by":"publisher","first-page":"954","DOI":"10.2337\/dc15-0184","volume":"38","author":"AS Krolewski","year":"2015","unstructured":"Krolewski AS. Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes. Diabetes Care. 2015;38(6):954\u201362.","journal-title":"Diabetes Care"},{"issue":"3","key":"1136_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1053\/j.ackd.2014.03.007","volume":"21","author":"SM Marshall","year":"2014","unstructured":"Marshall SM. Natural history and clinical characteristics of CKD in type 1 and type 2 diabetes mellitus. Adv Chronic Kidney Dis. 2014;21(3):267\u201372.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"4","key":"1136_CR5","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2215\/CJN.05191008","volume":"4","author":"K Abdel-Kader","year":"2009","unstructured":"Abdel-Kader K, Myaskovsky L, Karpov I, Shah J, Hess R, Dew MA, Unruh M. Individual quality of life in chronic kidney disease: influence of age and dialysis modality. Clin J Am Soc Nephrol. 2009;4(4):711\u20138.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"1136_CR6","doi-asserted-by":"publisher","first-page":"e2873","DOI":"10.1002\/dmrr.2873","volume":"33","author":"Antonio Pacilli","year":"2017","unstructured":"Pacilli A, Viazzi F, Fioretto P, Giorda C, Ceriello A, Genovese S, Russo G, Guida P, Pontremoli R, De Cosmo S. AMD-Annals study group. Epidemiology of diabetic kidney disease in adult patients with type 1 diabetes in Italy: the AMD-Annals initiative. Diabetes Metab Res Rev. 2017;33(4). \n                    https:\/\/doi.org\/10.1002\/dmrr.2873.","journal-title":"Diabetes\/Metabolism Research and Reviews"},{"issue":"1","key":"1136_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diabres.2014.10.014","volume":"107","author":"HH Parving","year":"2015","unstructured":"Parving HH, Persson F, Rossing P. Microalbuminuria: a parameter that has changed diabetes care. Diabetes Res Clin Pract. 2015;107(1):1\u20138.","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"1136_CR8","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.2337\/diabetes.52.4.1036","volume":"52","author":"ML Caramori","year":"2003","unstructured":"Caramori ML, Fioretto P, Mauer M. Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions. Diabetes. 2003;52(4):1036\u201340.","journal-title":"Diabetes"},{"key":"1136_CR9","doi-asserted-by":"crossref","unstructured":"Piscitelli P, Viazzi F, Fioretto P, Giorda C, Ceriello A, Genovese S, Russo G, Guida P, Pontremoli R, De Cosmo S. Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative. Sci Rep. 2017;7(1):3313.","DOI":"10.1038\/s41598-017-03551-w"},{"issue":"6","key":"1136_CR10","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1007\/s00125-017-4251-1","volume":"60","author":"Giuseppe Penno","year":"2017","unstructured":"Penno G, Russo E, Garofolo M, Daniele G, Lucchesi D, Giusti L, Sancho Bornez V, Bianchi C, Dardano A, Miccoli R, Del Prato S. Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus. Diabetologia. 2017;60(6):1102\u201313.","journal-title":"Diabetologia"},{"issue":"6","key":"1136_CR11","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.2337\/db08-1514","volume":"58","author":"MG Pezzolesi","year":"2009","unstructured":"Pezzolesi MG, Poznik GD, Mychaleckyj JC, Paterson AD, Barati MT, Klein JB, Ng DP, Placha G, Canani LH, Bochenski J, Waggott D, Merchant ML, Krolewski B, Mirea L, Wanic K, Katavetin P, Kure M, Wolkow P, Dunn JS, Smiles A, Walker WH, Boright AP, Bull SB, DCCT\/EDIC Research Group, Doria A, Rogus JJ, Rich SS, Warram JH, Krolewski AS. Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes. 2009;58(6):1403\u201310.","journal-title":"Diabetes"},{"key":"1136_CR12","doi-asserted-by":"crossref","unstructured":"Sandholm N, Van Zuydam N, Ahlqvist E, Juliusdottir T, Deshmukh HA, Rayner NW, Di Camillo B, Forsblom C, Fadista J, Ziemek D, Salem RM, Hiraki LT, Pezzolesi M, Tr\u00e9gou\u00ebt D, Dahlstr\u00f6m E, Valo E, Oskolkov N, Ladenvall C, Marcovecchio ML, Cooper J, Sambo F, Malovini A, Manfrini M, McKnight AJ, Lajer M, Harjutsalo V, Gordin D, Parkkonen M, FinnDiane Study Group, Tuomilehto J, Lyssenko V, McKeigue PM, Rich SS, Brosnan MJ, Fauman E, Bellazzi R, Rossing P, Hadjadj S, Krolewski A, Paterson AD, DCCT\/EDIC Study Group, Florez JC, Hirschhorn JN, Maxwell AP, GENIE consortium, Dunger D, Cobelli C, Colhoun HM, Groop L, MI MC, Groop PH, SUMMIT consortium. The genetic landscape of renal complications in type 1 diabetes. J Am Soc Nephrol. 2017;28(2):557\u201374.","DOI":"10.1681\/ASN.2016020231"},{"issue":"7448","key":"1136_CR13","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1136\/bmj.38070.450891.FE","volume":"328","author":"P Hovind","year":"2004","unstructured":"Hovind P, Tarnow L, Rossing P, Jensen BR, Graae M, Torp I, Binder C, Parving HH. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ. 2004;328(7448):1105.","journal-title":"BMJ"},{"issue":"4","key":"1136_CR14","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00592-015-0822-0","volume":"53","author":"M Feodoroff","year":"2016","unstructured":"Feodoroff M, Harjutsalo V, Forsblom C, Thorn L, Wad\u00e9n J, Tolonen N, Lithovius R, Groop PH. Smoking and progression of diabetic nephropathy in patients with type 1 diabetes. Acta Diabetol. 2016;53(4):525\u201333.","journal-title":"Acta Diabetol"},{"issue":"4","key":"1136_CR15","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1681\/ASN.2006080872","volume":"18","author":"BA Perkins","year":"2007","unstructured":"Perkins BA, Ficociello LH, Ostrander BE, Silva KH, Weinberg J, Warram JH, Krolewski AS. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. J Am Soc Nephrol. 2007;18(4):1353\u201361.","journal-title":"J Am Soc Nephrol"},{"key":"1136_CR16","doi-asserted-by":"crossref","unstructured":"De Cosmo S, Rossi MC, Pellegrini F, Lucisano G, Bacci S, Gentile S, Ceriello A, Russo G, Nicolucci A, Giorda C, Viazzi F, Pontremoli R, AMD-Annals Study Group. Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes. Nephrol Dial Transplant. 2014;29(3):657\u201362.","DOI":"10.1093\/ndt\/gft506"},{"key":"1136_CR17","doi-asserted-by":"crossref","unstructured":"De Cosmo S, Viazzi F, Pacilli A, Giorda C, Ceriello A, Gentile S, Russo G, Rossi MC, Nicolucci A, Guida P, Feig D, Johnson RJ, Pontremoli R, AMD-Annals Study Group. Serum uric acid and risk of CKD in type 2 diabetes. Clin J Am Soc Nephrol. 2015;10(11):1921\u20139.","DOI":"10.2215\/CJN.03140315"},{"key":"1136_CR18","doi-asserted-by":"crossref","unstructured":"Nicolucci A, Rossi MC, Arcangeli A, Cimino A, de Bigontina G, Fava D, Gentile S, Giorda C, Meloncelli I, Pellegrini F, Valentini U, Vespasiani G, AMD-Annals Study Group. Four-year impact of a continuous quality improvement effort implemented by a network of diabetes outpatient clinics: the AMD-Annals initiative. Diabet Med. 2010;27(9):1041\u20138.","DOI":"10.1111\/j.1464-5491.2010.03055.x"},{"key":"1136_CR19","doi-asserted-by":"crossref","unstructured":"Viazzi F, Piscitelli P, Giorda C, Ceriello A, Genovese S, Russo GT, Fioretto P, Guida P, De Cosmo S, Pontremoli R, AMD-Annals Study Group. Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes. J Diabetes Complicat. 2017;31(2):419\u201326.","DOI":"10.1016\/j.jdiacomp.2016.10.030"},{"issue":"9","key":"1136_CR20","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J. CKD-EPI (chronic kidney disease epidemiology collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"7","key":"1136_CR21","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1001\/jamainternmed.2014.1363","volume":"174","author":"HY Wu","year":"2014","unstructured":"Wu HY, Peng YS, Chiang CK, Huang JW, Hung KY, Wu KD, Tu YK, Chien KL. Diagnostic performance of random urine samples using albumin concentration vs ratio of albumin to creatinine for microalbuminuria screening in patients with diabetes mellitus: a systematic review and meta-analysis. JAMA Intern Med. 2014;174(7):1108\u201315.","journal-title":"JAMA Intern Med"},{"issue":"7","key":"1136_CR22","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.2337\/dc09-1098","volume":"33","author":"M. E. Molitch","year":"2010","unstructured":"Molitch ME, Steffes M, Sun W, Rutledge B, Cleary P, de Boer IH, Zinman B, Lachin J. Epidemiology of diabetes interventions and complications study group. Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study. Diabetes Care. 2010;33(7):1536\u201343.","journal-title":"Diabetes Care"},{"key":"1136_CR23","doi-asserted-by":"crossref","unstructured":"de Boer IH, Afkarian M, Rue TC, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Sun W, Zinman B. Diabetes control and complications trial\/epidemiology of diabetes interventions and complications (DCCT\/EDIC) research group. Renal outcomes in patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol. 2014;25(10):2342\u201350.","DOI":"10.1681\/ASN.2013091004"},{"issue":"5","key":"1136_CR24","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1053\/j.ajkd.2007.08.005","volume":"50","author":"T Costacou","year":"2007","unstructured":"Costacou T, Ellis D, Fried L, Orchard TJ. Sequence of progression of albuminuria and decreased GFR in persons with type 1 diabetes: a cohort study. Am J Kidney Dis. 2007;50(5):721\u201332.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"1136_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jdiacomp.2016.06.012","volume":"31","author":"P Bjornstad","year":"2017","unstructured":"Bjornstad P, Pyle L, Kinney GL, Rewers M, Johnson RJ, Maahs DM, Snell-Bergeon JK. Adiponectin is associated with early diabetic kidney disease in adults with type 1 diabetes: a coronary artery calcification in type 1 diabetes (CACTI) study. J Diabetes Complicat. 2017;31(2):369\u201374.","journal-title":"J Diabetes Complicat"},{"issue":"8287","key":"1136_CR26","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/S0140-6736(82)92450-3","volume":"1","author":"GC Viberti","year":"1982","unstructured":"Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet. 1982;1(8287):1430\u20132.","journal-title":"Lancet"},{"key":"1136_CR27","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1111\/dme.13430","volume":"341","author":"P Bjornstad","year":"2017","unstructured":"Bjornstad P, Costacou T, Miller RG, Maahs DM, Rewers MJ, Orchard TJ, Snell-Bergeon JK. Predictors of early renal function decline in adults with type 1 diabetes: the coronary artery calcification in type 1 diabetes and the Pittsburgh epidemiology of diabetes complications studies. Diabet Med. 2017;341:1532\u201340.","journal-title":"Diabet Med"},{"issue":"5","key":"1136_CR28","doi-asserted-by":"publisher","first-page":"889","DOI":"10.2337\/dc08-1560","volume":"32","author":"LH Ficociello","year":"2009","unstructured":"Ficociello LH, Perkins BA, Roshan B, Weinberg JM, Aschengrau A, Warram JH, Krolewski AS. Renal hyperfiltration and the development of microalbuminuria in type 1 diabetes. Diabetes Care. 2009;32(5):889\u201393.","journal-title":"Diabetes Care"},{"key":"1136_CR29","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/BF00860729","volume":"9","author":"F Chiarelli","year":"1995","unstructured":"Chiarelli F, Verrotti A, Morgese G. Glomerular hyperfiltration increases the risk of developing microalbuminuria in diabetic children. Pediatr Nephrol. 1995;9:154\u20138.","journal-title":"Pediatr Nephrol"},{"key":"1136_CR30","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00125-009-1268-0","volume":"52","author":"GM Magee","year":"2009","unstructured":"Magee GM, Bilous RW, Cardwell CR, Hunter SJ, Kee F, Fogarty DG. Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia. 2009;52:691\u20137.","journal-title":"Diabetologia"},{"key":"1136_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1042\/CS20070088","volume":"114","author":"DZ Levine","year":"2008","unstructured":"Levine DZ. Can rodent models of diabetic kidney disease clarify the significance of early hyperfiltration? Recognizing clinical and experimental uncertainties. Clin Sci (Lond). 2008;114:109\u201318.","journal-title":"Clin Sci (Lond)"},{"key":"1136_CR32","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1056\/NEJM198207223070403","volume":"307","author":"BM Brenner","year":"1982","unstructured":"Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med. 1982;307:652\u20139.","journal-title":"N Engl J Med"},{"key":"1136_CR33","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/ki.1983.72","volume":"23","author":"BM Brenner","year":"1983","unstructured":"Brenner BM. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int. 1983;23:647\u201355.","journal-title":"Kidney Int"},{"issue":"6","key":"1136_CR34","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1172\/JCI112521","volume":"77","author":"R Zatz","year":"1986","unstructured":"Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest. 1986;77(6):1925\u201330.","journal-title":"J Clin Invest"},{"issue":"4","key":"1136_CR35","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/NEJMoa1515920","volume":"375","author":"C Wanner","year":"2016","unstructured":"Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten M, Mattheus M, Johansen OE, Woerle HJ, Broedl UC, Zinman B, Investigators EMPA-REGOUTCOME. Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med. 2016;375(4):323\u201334.","journal-title":"N Engl J Med"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1136-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-018-1136-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1136-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T19:17:23Z","timestamp":1575400643000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-018-1136-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1136"],"URL":"https:\/\/doi.org\/10.1186\/s12882-018-1136-6","relation":{},"ISSN":["1471-2369"],"issn-type":[{"type":"electronic","value":"1471-2369"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"1 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval and informed consent to participate was not required given that the automated anonymized database precludes identification of individual patients (<i>Linee guida per i trattamenti di dati personali nell\u2019ambito delle sperimentazioni cliniche di medicinali - 24 luglio 2008 - G.U. n. 190 del 14 agosto 2008 - Guidelines for Personal Data Processing in Clinical Trials of Medicines - July 24, 2008 - Official Gazette n. 190, August 14, 2008<\/i>).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"347"}}